This week in gene and cell therapy - 18 May 2018

Gene and cell therapy headlines 14 - 18 May

Michele De Luca and Alexander Meissner elected to EMBO membership

David Liu, Feng Zhand and Keith Joung launch new company, Beam Therapeutics

Concerns grow over DIY gene editing "biohackers"

NovoNordisk announces partnership with BioLamina to bolster cell therapy

Calls for patient registries of gene and cell therapy clinical trials

Cell and Gene Therapy Catapult annonces funding to promote integration of gene and cell therapy into UK health services

TapImmune and Marker Therapeutics merge to develop new T cell therapies

Bioverativ Inc' BIVV003, a gene-edited cell therapy candidate for sickle cell disease obtains IND status from the FDA